RMEI header logo

                                                                       

Hematologic Malignancies CME

We provide cutting edge research about newly approved and emerging treatments for leukemia, lymphoma, and myeloma to hematologists and oncologists who diagnose and treat patients with hematologic malignancies.

 

Online Activities

 

Precision and Emerging Medicine for Hematological Diseases

The intention of this activity is to provide hematologists and oncologists with up-to-date research and treatments for leukemia, lymphoma, and myeloma in order to create a precision medicine framework and improve outcomes of patients with hematologic malignancies.